Home / Moved to Main Board / ANG Lifesciences India
ANG Lifesciences India: IPO, Share Price and Results Since Listing
ANG Lifesciences India moved from BSE SME to the BSE main board. For Q2 FY2027 it reported revenue of INR 20.10 crore (-22.85% on a year earlier) and a loss of INR 2.09 crore.
Key Facts
- Moved to
- BSE main board (BSE does not publish the date)
- Listed on BSE SME
- 8 September 2017
- Symbol
- ANG (BSE code 540694)
- Latest close
- INR 41.17 on 13 November 2026
Results Filed With BSE
Consolidated figures, INR crore. Change compares with the same period a year earlier.
| Period | Revenue | Change | Profit after tax | EPS (INR) | Filed | |
|---|---|---|---|---|---|---|
| Q2 FY2027 | 20.10 | -22.85% | -2.09 | -1.59 | after listing | 15 November 2026 |
| Q1 FY2027 | 15.30 | -37.82% | -4.24 | -3.24 | after listing | 14 August 2026 |
| Q4 FY2026 | 23.50 | +39.70% | -1.38 | -1.07 | after listing | 30 May 2026 |
| FY2026 | 92.89 | +0.05% | -11.08 | -8.43 | after listing | 30 May 2026 |
| Q3 FY2026 | 18.73 | – | -4.75 | -3.60 | after listing | 14 February 2026 |
| Q2 FY2026 | 26.05 | – | -2.95 | -2.24 | after listing | 14 November 2025 |
| Q1 FY2026 | 24.60 | – | -2.01 | -1.52 | after listing | 14 August 2025 |
| Q4 FY2025 | 16.82 | – | -2.06 | -1.56 | after listing | 30 May 2025 |
| FY2025 | 92.85 | – | -12.41 | -9.42 | after listing | 30 May 2025 |
Promoter Holding
Promoter holding has moved from 70.60% on 31 December 2025 to 70.60% on 30 September 2026 (0 percentage points).
| As of | Promoters | Public |
|---|---|---|
| 30 September 2026 | 70.60% | 29.40% |
| 30 June 2026 | 70.60% | 29.40% |
| 31 March 2026 | 70.60% | 29.40% |
| 31 December 2025 | 70.60% | 29.40% |
Sources: BSE filings (results XBRL, shareholding pattern, board meetings), BSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.